Skip to content

Clinical trials

Thyroid Neoplasms trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Neoplasms Phase: Not applicable Clear all

186 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20051
20062
20071
20085
20092
20104
20116
20128
20137
20146
20153
20169
20176
201816
20195
202015
20219
202223
202312
20247
202519
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed74
Unknown status49
Recruiting34
Not yet recruiting12
Terminated9
Active, not recruiting4
Withdrawn3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fujian Medical University8
Yonsei University8
Cedars-Sinai Medical Center4
M.D. Anderson Cancer Center4
Second Affiliated Hospital, Zhejiang University, School of Medicine4
Bo Wang,MD3
Mayo Clinic3
Medstar Health Research Institute3
Memorial Sloan Kettering Cancer Center3
Radboud University Medical Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Neoplasms186
Thyroid Nodule29
Breast Neoplasms15
Head and Neck Neoplasms13
Prostatic Neoplasms13
Thyroid Cancer, Papillary13
Thyroid Diseases13
Neoplasms12
Colorectal Neoplasms8
Colonic Neoplasms7

Trials

Showing 26 to 50 of 186. Each trial links to its page on Pharma Observatory.

86 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.